<DOC>
	<DOC>NCT01522807</DOC>
	<brief_summary>The purpose of the study is to evaluate the plasma drug concentrations of three formulations of PF-05190457 after administration of single doses to healthy volunteers.</brief_summary>
	<brief_title>A Study Of Three PF-05190457 Formulations In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Healthy males and females of nonchildbearing potential between ages of 21 and 55 years, BMI of 17.5 to 30.5 kg/m^2, and weight above 50 kg. Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Single Doses</keyword>
	<keyword>Biocomparison</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>